FDA agrees to Armata's pediatric study plan for AP-SA02 bacteremia drug
Go back to FDA agrees to Armata's pediatric study plan for AP-SA02 bacteremia drug| Aurum Resources Corp (NYSE: ARMP) | Delayed: 4.18 +0.08 (1.95%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.10 | 52 Week High | $2.00 | |||
| Open | $4.07 | 52 Week Low | $1.50 | |||
| Day High | $4.40 | P/E | N/A | |||
| Day Low | $4.00 | EPS | $0.00 | |||
| Volume | 160,608 | |||||
